𝔖 Bobbio Scriptorium
✦   LIBER   ✦

ALTERED PHENOTYPIC CHARACTERISTICS OF T47D HUMAN BREAST CANCER CELLS AFTER PROLONGED GROWTH IN ESTROGEN-DEFICIENT MEDIUM

✍ Scribed by Pat Fernandez; Cody Wilson; Debie Hoivik; Stephen H. Safe


Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
314 KB
Volume
22
Category
Article
ISSN
1065-6995

No coin nor oath required. For personal study only.

✦ Synopsis


T47D human breast cancer cells were cultured in estrogen-deficient media for up to 32 months and the resulting cell line (L(hE(-))) exhibited unique phenotypic and genotypic characteristics. Compared to low passage (L) cells, the L(hE(-)) cells exhibited a significantly higher rate of proliferation, unique morphological features, advanced ploidy status and 5- to 10-fold higher levels of the estrogen receptor (ER) as determined by ligand binding and Western blot analysis. Sequence analysis of the DNA binding domain of the ER revealed a C-->A transversion which resulted in a H513N amino acid change. Treatment of L cells with 10 n m 17beta-estradiol (E2) resulted in a greater than two-fold increase in cell proliferation which was inhibited by tamoxifen, 4'-hydroxytamoxifen, ICI 164,384 and ICI 182,780. In contrast, 10 n m E2 caused a 70% decrease in growth of L(hE(-)) cells and this antimitogenic activity was blocked by ICI 164,384 and ICI 182,780 but not by tamoxifen or 4'-hydroxytamoxifen. L(hE(-)) cells were E2-responsive in transient transfection studies using a plasmid containing an estrogen-responsive element derived from the vitellogenin A2 gene promoter. These data show that the phenotypic and genotypic characteristics of L(hE(-)) T47D cells resemble those described for ER-negative cell lines stably transfected with the ER.


πŸ“œ SIMILAR VOLUMES


Interaction of growth factors during pro
✍ Roger J. Daly; Roger J. B. King; Philippa D. Darbre πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 874 KB

When deprived of steroid in the long term, T-47-D human breast cancer cells lose estrogen sensitivity of cell growth. This loss of response results from an increased basal growth rate in the absence of steroid, not from a loss of estrogen-stimulated growth, and it occurs without any loss of estrogen

Mitogenic stimulation of human breast ca
✍ Bart van der Burg; Gerard R. Rutteman; Marinus A. Blankenstein; Siegfried W. de πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 888 KB

The cooperative action of l7p-estradiol (E2) and polypeptide growth factors in stimulating proliferation of human breast cancer cells in vitro was investigated. To prevent background estrogenic stimulation, only phenol red-free media were used. When cultured in media supplemented with steroidstrippe

Characterization of the effects of the n
✍ Jacques Simard; Claude Labrie; Alain BΓ©langer; Sylvain Gauthier; Shankar M. Sing πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 256 KB πŸ‘ 2 views

Since estrogens play a predominant role in the development and growth of human breast cancer, antiestrogens represent a logical approach to the treatment of this disease. The present study compares the effects of the novel nonsteroidal anti-estrogen EM-800 and related compounds with those of a serie